Alto Neuroscience

Showing 2 posts of 2 posts found.

Alto Neuroscience announces new patent for depression treatment

January 15, 2026
Sales and Marketing Alto Neuroscience, Psychiatry, depression

Alto Neuroscience, a clinical-stage biopharmaceutical company specialising in precision treatments for neuropsychiatric conditions, has announced the issuance of a US …

brain_anatomy_medical_head_skull_digital_3_d_x_ray_xray_psychedelic_3720x2631_1

Alto Neuroscience’s schizophrenia treatment granted FDA Fast Track designation

October 14, 2025
Alto Neuroscience, FDA, schizophrenia

Alto Neuroscience has announced that its investigational treatment for cognitive impairment associated with schizophrenia (CIAS) has received Fast Track designation …

The Gateway to Local Adoption Series

Latest content